Brucellosis

Version: November 2025

Introduction

Brucellosis is a zoonotic infectious disease caused by bacteria of the genus Brucella. It primarily affects animals such as cattle, goats, sheep, pigs, and dogs, but can also be transmitted to humans through direct contact with infected animals or consumption of contaminated animal products, like unpasteurized milk and cheese. In humans, brucellosis presents with flu-like symptoms, including fever, sweats, and malaise, and can lead to chronic infection if untreated. While its incidence has declined in developed countries due to animal vaccination and pasteurization, it remains a significant public health issue in many parts of the world.

Highlights

Analysis

Cases Analysis

The data on brucellosis cases in mainland China from November 2015 to November 2025 indicates fluctuating infection rates. Starting with 3078 cases in November 2015, there is an upward trend, peaking in May 2021 with 8096 cases. This suggests potential seasonal or occupational factors influencing disease spread, particularly during spring and summer when interactions with livestock increase. This trend reflects the consistent rise in cases during warmer months, although it occasionally extends into autumn.

Despite the high incidence rates, reported deaths are minimal, with years like 2016 through 2025 experiencing zero to two fatalities annually. This disparity implies effective clinical management, possibly aided by robust antibiotic protocols, keeping mortality low despite thousands of monthly cases. Variations with yearly deaths, consistently around one, indicate that while brucellosis is widespread, the risk of severe health outcomes or mortality is contained, likely through improved public health responses.

The pattern underscores the importance of focusing not only on treating brucellosis but also on robust prevention and control measures. Effective management has kept fatalities and severe health impacts low, prompting continued emphasis on occupational safety, veterinary public health interventions, and education, especially targeting vulnerable populations during high-incidence periods. This approach ensures sustained control over the disease while minimizing its human health impact.

Deaths Analysis

Brucellosis-related deaths within the Chinese mainland from November 2015 to November 2025 are notably rare occurrences in comparison to the volume of reported cases. Across this decade-long dataset, only 24 deaths are recorded amidst a backdrop of fluctuating case numbers that at times exceeded more than 9,000 cases per month. Despite the seasonal oscillations in case counts, mortality remains remarkably low, reflecting the effectiveness of medical interventions and public health measures in managing the disease’s fatal consequences.

Despite periodic increases in case numbers, the low mortality rate suggests possible strengths in the healthcare system’s capacity to manage and prevent severe outcomes associated with Brucellosis. The distribution of deaths does not show a marked concentration in any specific year or month, indicating that the effective response mechanisms remain consistent despite variations in case load. Furthermore, the sporadic occurrence of deaths, even during months of higher incidence rates, reinforces the notion that while Brucellosis is prevalent, it has not often transitioned into widespread fatality, underscoring that enhanced surveillance and treatment protocols might be effectively mitigating critical risk factors associated with mortality from this disease.

Source Data

Github